Return to top
RFXCEL, PART OF ANTARES VISION GROUP, AND MVC SIGNED AN AGREEMENT WITH LEBANESE REPUBLIC TO DEPLOY END-TO-END PHARMA TRACEABILITY HUB
RFXCEL, PART OF ANTARES VISION GROUP, AND MVC SIGNED AN AGREEMENT WITH LEBANESE REPUBLIC TO DEPLOY END-TO-END PHARMA TRACEABILITY HUB

RFXCEL, PART OF ANTARES VISION GROUP, AND MVC SIGNED AN AGREEMENT WITH LEBANESE REPUBLIC TO DEPLOY END-TO-END PHARMA TRACEABILITY HUB


Travagliato (Brescia), 22 September 2021 –
Antares Vision Group, the international leader in the pharmaceutical sector for track & trace hardware and software solutions (anti-counterfeiting and supply chain transparency), with an established presence in inspection systems (quality control), and active in smart data management (production efficiency and end-to-end supply chain digitalization, from raw materials to the final consumer), announced today that its subsidiary rfxcel has signed a five-year cooperative agreement with the Lebanese Republic’s Ministry of Public Health to provide a GS1-compliant Traceability Hub to secure the country’s entire pharmaceutical supply chain. The company will implement the system with its partner Medical Value Chain (MVC), the Bahrain subsidiary of U.S.-based AVC Global.

 

The announcement comes only a few months after rfxcel and MVC were selected by Bahrain’s National Health Regulatory Authority and Supreme Council of Health to provide the first GS1- compliant system to track the Kingdom’s entire pharmaceutical supply chain on a blockchain platform.

 

The Lebanon Traceability Hub will deliver end-to-end visibility into every aspect of the country’s pharmaceutical supply chain, from the manufacturer of origin, importers, wholesalers, and distributors to pharmacies, clinics, and hospitals — all the way to individual patients. It will integrate with the Ministry of Public Health’s MediTrack system for domestic manufacturers.

 

The Hub is designed to achieve the following:

  • Lower the cost of pharmaceuticals
  • Provide patients with only authentic, safe medications
  • Combat drug counterfeiting and smuggling
  • Ensure access to pharmaceuticals subsidized by the Banque du Liban, the central bank of Lebanon
  • Prevent hoarding of medicines

 

Glenn Abood, rfxcel CEO, said: “The Hub is all about leveraging leading-edge technology to secure Lebanon’s pharmaceutical supply chain and safeguard patients and consumers. Security and safety — these are the very reasons I founded rfXcel almost 20 years ago. We’re eager to begin our work with MVC in Lebanon, and we’ll continue to focus on bringing Traceability Hubs to other countries in the Middle East and beyond.”

 

MVC Co-Founder and President Leo Giacometto said, “The MVC technology platform with blockchain revolutionizes the delivery and integrity of pharmaceutical supply chains in Lebanon. We are excited and honored to deploy our platform in partnership with the Ministry of Public Health in the Republic of Lebanon.”